Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Veidekke: New commission for SINTEF in Trondheim

Veidekke has signed a contract with SINTEF Energi AS to build SINTEF Horizon, an eco-certified commercial building on the Gløshaugen university campus in Trondheim. The commission is a design and build contract valued at NOK 280 million, excluding VAT.The new building will total 11,000 m[2 ]in size, of which 6,500 m[2] is a new build and the remaining 4,500 m[2] is rehabilitation of an existing office building. SINTEF Horizon will accommodate office spaces, areas designed for interaction and research, and a canteen for employees and other users of the campus. The project aims to become a

McLaren Proton Therapy Center – Karmanos Cancer Institute, selects RayStation for proton planning

RaySearch Laboratories AB (publ) announces that McLaren Proton Therapy Center in Flint, Michigan, has placed an order for the treatment planning system RayStation®*.The McLaren Proton Therapy Center has a long history of proton treatments in the Detroit and eastern Michigan area. The center is the only National Cancer Institute (NCI) - designated comprehensive cancer center in metropolitan Detroit and one of just 51 centers of its kind in the United States. Since 2018, the center's capacity has grown, and they have recently treated their 600th patient. The RayStation purchase will

Gold for Wallenstam’s headquarters

Wallenstam’s headquarters has been awarded the gold prize in the Environmental Building In-Use (Miljöbyggnad iDrift) category in the Sweden Green Building Awards 2022 competition. Both Wallenstam’s headquarters and the regional office in Stockholm have been recently certified in the gold category according to the Environmental Building In-Use rating system developed by the Swedish Green Building Council (SGBC).The motivation for the award reads as follows: “The winning property is a good example which demonstrates that a building can be sustainable over time. Although it is an older

Nomination committee for Scandic’s AGM 2023 appointed

In accordance with the instruction to the Nomination Committee, Scandic’s Nomination Committee is made up of Scandic’s three largest shareholders as per August 31, 2022, and the Chair of the Board of Directors. Prior to the Annual General Meeting 2022, the Nomination Committee is composed as follows:· Karl Swartling, Stena Sessan AB, Chair of the Nomination Committee · Dick Bergqvist, AMF · Trygve Hegnar, Periscopus AS · Per G. Braathen, Chair of the Board of Directors · Camilla Köhler, General Counsel and Secretary of the Nomination Committee Shareholders wishing to submit

Smoltek publishes newsletter on technical progress, recruitments and the company's rights issue

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek Nanotech Holding AB (“Smoltek”) publishes a new edition of its newsletter aimed at shareholders, investors and other stakeholders within the company's business areas Semiconductors (ultra-thin capacitors) and Hydrogen (high-performance cell material for hydrogen gas production).The newsletter highlights presentations made at two international conferences on Smoltek’s technical achievements in ultra-thin capacitors and high-performance cell material to

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 222 - 28 OCTOBER 2022 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

INTELLilight from TYRI has been awarded the Red Dot Design Award for its innovative design

Intelligent work lighting systems that offer new possibilities for both the user and the installer. INTELLilight is a flexible lighting solution for work machines that can be adapted to the operators needs and to the environment with which they are working in.The app that gave the award It’s the app’s design and functionality that raised the eyebrows of the Red Dot Award jury.  Via the app you can control all the lighting, by either grouping, adjusting the lighting strength or colour temperature; all achieved from outside the operator’s area and entirely based on the driver's preferences

Nomination Committee for Bravida Holding AB’s AGM 2023

In accordance with the decision at Bravida Holding AB’s Annual General Meeting on 5 May 2023, the largest shareholders in terms of votes at the end of July 2022 has appointed the following persons to be part of Bravida’s Nomination Committee ahead of the Annual General Meeting of 2023.· Joachim Spetz, Swedbank Robur fonder (Chairman) · Lovisa Runge, Fjärde AP-fonden · Henrik Didner, Didner & Gerge · Fredrik Arp, Chairman Bravida Holding AB (adjunct member) Shareholders who wish to submit proposals to Bravida's nomination committee are welcome to submit their proposals by e-mail

Interim Report Q3 January-September 2022

Customer demand was very strong, resulting in the second highest quarterly net sales level ever. Our modern connected lighting solutions help customers reduce energy consumption by up to 90%.The third quarter: · Order intake was MSEK 1,891 (1,895), a decrease of -0.2% adjusted to -5.2% for currency effects of MSEK +94 · Net sales were MSEK 2,081 (1,745), an increase of +19.3% adjusted to +13.0% for currency effects of MSEK +109 · Operating profit was MSEK 218.8 (184.2), an increase of +18.8% with an operating margin of 10.5 (10.6)% · Earnings after tax were MSEK 156.9 (127.6)

Inhalation Sciences signs IRS order worth 1.17 million SEK with large generic pharma company

Inhalation Sciences has signed a new contract worth 1.17 million SEK (107,600 Euros) for an Inhalation Research Service (IRS) project aiming to establish differences in the dissolution profiles between a generic inhaled therapy and its reference drug – a key component of bioequivalence.Dissolution data are a crucial component of bioequivalence, a key requirement that  a generic drug needs to comply to for regulatory approval. Bioequivalence is particularly challenging to define for inhaled drugs - a fast-growing market segment that is forecast to grow from 17.5 BUSD (2021) to 38.45 BUSD by

BioStock: Important year for life science as Sweden holds the EU presidency

During the first half of 2023, all eyes will be on Sweden as the country takes over the presidency of the EU. All signs points to the coming spring being very eventful as many crucial issues are to be addressed. Among other things, there will be a major review of the common European regulatory framework for medicines.Read the full article on the crucial EU issues at  biostock.se/en: https://www.biostock.se/en/2022/10/important-year-for-life-science-as-sweden-holds-the-eu-presidency 

Nordic Paper increases ambition in its climate targets

Nordic Paper has adopted new targets for reduction of its climate impact. The total emissions of fossil greenhouse gases from Nordic Paper activities, including indirect emissions from purchased goods and services, are to be reduced by 50% to 2030 compared with 2020. In addition, the direct emissions from the company’s own activity and from purchased energy are to be reduced by at least 50% for the same period of time. Nordic Paper manufactures specialised kraft papers and natural greaseproof papers for use primarily in the food sector. The papers are produced from locally sourced

Nomination Committee of Medivir appointed

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the nomination committee now has been appointed ahead of the Annual General Meeting in May 2023.According to an AGM resolution, the Nomination Committee 2022-2023 should consist of representatives of at least the three largest shareholders at the end of the third quarter of 2022 and the Chairman of the Board.  Work on composing the Nomination Committee is now completed, and this year’s Nomination Committee consists of: Karl Tobieson (Chairman), appointed by Linc ABRichard Torgerson, appointed by Nordea

Alimak Group appoints Johnny Nylund as Chief Communications Officer

Johnny Nylund is currently Head of Press and Public Affairs at Sweco, Europe’s leading architecture and engineering company, listed on Nasdaq Stockholm. Johnny has previously held similar positions at Business Sweden, AkzoNobel and Swedish Radio, and has experience from the PR industry.“I am very happy to welcome Johnny Nylund to Alimak Group. The experience he will bring to the role of Chief Communications Officer will help us drive excellence in external and internal communications”, says Ole Kristian Jødahl, CEO Alimak Group.“Alimak group is a company with a strong customer focus and

Invitation to presentation of Cantargia’s report for the third quarter of 2022 on November 10 at 3.00 p.m. CET

Cantargia AB will publish the company’s report for the third quarter of 2022 on Thursday, November 10, 2022, at 08:30 a.m. CET.In conjunction to the report, Cantargia invites investors, analysts, and media to an audiocast with teleconference (in English) on November 10, at 3:00 p.m. CET, where Göran Forsberg, CEO, and Bengt Jöndell, CFO, will present Cantargia and comment on the quarterly report for the third quarter 2022, followed by a Q&A-session. The conference call can be followed at: https://tv.streamfabriken.com/cantargia-q3-2022 To attend through telephone, please dial-in at

BPC Instruments’ CEO interviewed by Börsvärlden

BPC Instruments AB (“BPC” or “the Company”) CEO Dr. Jing Liu is interviewed by Börsvärlden about the Company, its expansive growth, and future visions.BPC has had an eventful first year as a listed company on Spotlight Stock Market and has shown great financial results with stable growth over the last three years despite unstable times in the world. CEO Dr. Jing Liu is interviewed by the Swedish financial news agency Börsvärlden about the Company, BPC’s expansive growth, and future visions. “…We are also seeing an increasing customer base from top manufacturers, research institutes and

Sleep Cycle interim report July-September 2022: Continued growth, strong operating margin, and a partnership breakthrough

Despite a tough prevailing economic climate, Sleep Cycle continued to show strong performance in the third quarter. Income increased by 12.8% to SEK 55.0 million, and the operating margin totaled 24.7 (24.6)%, exceeding the long-term target of 20%. The somewhat weaker growth in income compared with prior quarters was to some extent, in addition to subscription revenue, due to compensation for engineering work from Samsung in the third quarter of 2021. Adjusted for this compensation, growth in income was 20.9%. Partnering with Gympass was a high point of the third quarter, as this quickly

Stenocare accesses the Norwegian market. Stenocare has signed a distribution agreement with the leading distributor and pharmacy chain.

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO STENOCARE A/S (“Stenocare”) now enters its 5th market. Stenocare has distribution agreement with the leading distributor and pharmacy chain in Norway, Apotek1, to secure nationwide distribution from day one. The three new oil-based products will be the first of their kind in Norway and will be available as prescription-based medicine via all Norwegian pharmacies.#1 in Norway: Stenocare is the first and so far, only supplier of oil based medical cannabis products in Norway with a portfolio of three full spectrum

PostNord: Third quarter 2022 – challenging macro situation requires continued adaption of the business

Third quarter 2022 · Net sales totaled SEK 9,456 million (9,340), a decrease of -2 percent (5) in fixed currency for like-for-like units · Overall, parcel volumes decreased by -4 percent (6) due to lower business-to-consumer volumes  · Mail volumes decreased by -11 percent (-9)  · Operating income (EBIT) totaled SEK 65 million (323)Comments from Annemarie Gardshol, CEO Challenging macro situation requires continued adaption of the business  The Group’s sales totaled SEK 9,456 million (9,340) in the quarter, a decrease of -2 percent (5) in fixed currency for like-for-like

TF Bank appoints Nomination Committee ahead of 2023 Annual General Meeting

TF Bank today announces the composition of the Nomination Committee ahead of the 2023 Annual General Meeting, which will be held on Wednesday, 3 May 2023. The Nomination Committee will prepare proposals to be submitted to the 2023 AGM regarding Chairman for the General Meeting, Board of Directors, Chairman of the Board and auditors as well as board and auditor fees and fees for committee work. According to the guidelines for appointment of the Nomination Committee resolved by the Annual General Meeting in 2021, the largest shareholders in terms of voting power who wish to participate in

Metsä Fibre recognised with an international award for future-focused work

Metsä Group press release 28 October 2022Metsä Fibre, part of Metsä Group, has won international recognition in the EFQM Excellence Award competition. The company achieved EFQM Global Award 2022 7 Diamonds rating and has been awarded the Outstanding Achievement for Future Focus recognition. The company was again able to improve its results compared to previous years. Metsä Fibre received special praise from the EFQM assessors for a strong focus on the future and the outstanding ability to combine long-term vision and strategy with the daily operations in the short term as well. “We’re

BioStock: Invent Medic highlights the needs connected with stress urinary incontinence

Stress urinary incontinence is a widespread problem that affects millions of women around the world. It is also a problem that can be difficult to talk about and not all women are aware of the help available to overcome the problems. Lund-based Invent Medic, that markets Efemia bladder support, plays an active part in informing women about the available help.Read the full article at biostock.se: https://www.biostock.se/en/2022/10/invent-medic-highlights-the-needs-connected-with-stress-urinary-incontinence/ This is a press release from BioStock - Connecting Innovation & Capital. https:/

Interim report January 1 - September 30, 2022

July-September 2022 Net revenue for the period was SEK 237.0 million (105.6), an increase of 124.5 %. Organic growth was 27.2 %. Orders received for the period was SEK 268.4 million (107.1), an increase of 150.7 %. Organic growth was 20.6 %. Adjusted EBITDA for the period was SEK 36.0 million (14.5) EBITDA for the period was SEK 39.2 million (13.3) Profit/loss for the period was SEK 33.9 million (-1.6) Earnings per share for the period amounted to SEK 0.19 (-0.01) Cash flow from Operations for the period was SEK 20.8 million January-September 2022 Net revenue for

There are no items matching the current filter
There are no more items matching the current filter
Back to top